INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 281 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,951 | -19.8% | 14,397 | -2.5% | 0.36% | -16.9% |
| Q2 2023 | $935,187 | +16.0% | 14,769 | -0.8% | 0.43% | -1.1% |
| Q1 2023 | $806,522 | -2.7% | 14,894 | -4.9% | 0.44% | -16.8% |
| Q4 2022 | $828,686 | +7.3% | 15,659 | -5.7% | 0.52% | +8.9% |
| Q3 2022 | $772,000 | -79.8% | 16,600 | -75.2% | 0.48% | -78.6% |
| Q2 2022 | $3,820,000 | -15.4% | 66,925 | -9.3% | 2.25% | +15.5% |
| Q1 2022 | $4,514,000 | +11.1% | 73,772 | -5.0% | 1.95% | +26.6% |
| Q4 2021 | $4,062,000 | – | 77,622 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |